Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.


Clinical Trial Description

Multiple studies have shown that people who are taking opioids for acute pain have a greater likelihood of long-term opioid use. Many efforts have been made to reduce postop pain and opioid use, including developments in incisional site injections of local anesthetics, continuous incisional site anesthetic pain pumps, as well as multimodal comprehensive pain management, yet patients undergoing lumbar spine surgeries continue to depend on opioids for relief. Liposomal bupivacaine (LB) (Exparel) is a novel formulation of long-acting bupivacaine, lasting for up to 72 hours following injection. LB has been shown to be efficacious in reducing postop pain and opioid utilization in several different surgical settings, however its utility in spine surgeries has still yet to be established. The goal of this study is to determine the efficacy of liposomal bupivacaine vs saline in lumbar spine surgeries in reducing opioid utilization as well as determine if there difference patient reported outcomes and length of hospital stay. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04644796
Study type Interventional
Source University of Missouri-Columbia
Contact
Status Completed
Phase Phase 4
Start date February 10, 2021
Completion date June 13, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04140344 - The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions N/A
Completed NCT04914728 - Mini-invasive Lumbar Arthrodesis in Ambulatory N/A
Recruiting NCT05527145 - Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial N/A
Completed NCT05630404 - Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block N/A
Recruiting NCT05452694 - OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
Recruiting NCT04823858 - 3Spine Lumbar Fusion Real World Evidence Study
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Recruiting NCT04781517 - Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion
Completed NCT03977961 - The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
Completed NCT03176303 - Study Using the SpinalStim Device Following Lumbar Fusion Surgery
Recruiting NCT06462729 - LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) Phase 1/Phase 2
Completed NCT01143324 - A Prospective, Multicenter Observational Study on MASTâ„¢ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
Active, not recruiting NCT05438719 - MOTUS Total Joint Replacement Investigational Device Exemption Study N/A
Not yet recruiting NCT05388383 - Cost-effectiveness Analysis of Robot-assisted Spinal Surgery
Completed NCT06316921 - Epidural PCA on Pain Relief After L-spine Surgery
Completed NCT03452449 - Physical Activity, Disability and Quality of Life Before and After Lumbar Spine Surgery
Terminated NCT03527966 - rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures Phase 4
Withdrawn NCT05408923 - Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery Phase 4
Terminated NCT01415908 - INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine Phase 3
Completed NCT04062942 - The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)